Halloysite nanotubes-based nanomaterials as drug carriers and scaffolds for personalized oral and maxillofacial applications
Journal of Drug Delivery Science and Technology · vol. 119 · 108141-108141
المخرجات
Articles, reviews, conference papers and book chapters, indexed by DOI and linked to University researchers.
646 output
Journal of Drug Delivery Science and Technology · vol. 119 · 108141-108141
Journal of Chromatography B · vol. 1272 · 124927-124927
International Communications in Heat and Mass Transfer · vol. 174 · 110904-110904
Journal of Drug Delivery Science and Technology · vol. 119 · 108140-108140
Applied Thermal Engineering · vol. 290 · 130093-130093
International Journal of Polymeric Materials · vol. 75 (8) · 835-858
Folate-conjugated chitosan nanoparticles represent a promising advancement in targeted drug delivery, offering enhanced specificity, biocompatibility, and controlled release profiles. Chitosan, a versatile biopolymer, provides a stable platform for nanoparticle synthesis, while folate conjugation enables selective targeting of folate receptors, which are overexpressed in various cancers and inflammatory diseases. This review explores the structural and functional properties of chitosan, mechanisms of folate receptor-mediated endocytosis, and innovative strategies for nanoparticle synthesis and functionalization. The review entails key formulation techniques, including nanoprecipitation, ionic gelation, and spray drying, alongside characterization methods essential for optimizing therapeutic efficacy. The biomedical applications of Folate-conjugated chitosan nanoparticles are highlighted in cancer therapy, gene delivery, and anti-inflammatory treatments, with an emphasis on emerging trends such as CRISPR-based targeting and dual-ligand strategies. This review critically examines the existing challenges and explores future directions, highlighting the promising role of folate-conjugated chitosan nanoparticles in the evolution of precision medicine.
Naunyn-Schmiedeberg s Archives of Pharmacology · vol. 399 (10) · 16225-16246
NeuroToxicology · vol. 114 · 103448-103448
Tissue and Cell · vol. 101 · 103454-103454
Tissue and Cell · vol. 101 · 103413-103413
Journal of Alloys and Compounds · vol. 1057 · 186813-186813
Folia Microbiologica
European Journal of Clinical Microbiology & Infectious Diseases · vol. 45 (5) · 1307-1321
Toxicology Mechanisms and Methods · vol. 36 (3) · 412-431
Methotrexate (METX) is a widely used chemotherapeutic and immunosuppressive agent, frequently employed as a first-line treatment for various malignancies and autoimmune disorders. Despite its clinical efficacy, METX is known to induce cardiotoxicity primarily through mechanisms involving oxidative stress, inflammation, and apoptosis. Apigenin (API), a natural dietary flavonoid, exhibits potent antioxidant and anti-inflammatory properties. The current study evaluated the protective effects of API against METX-induced cardiotoxicity in mice, focusing on the modulation of transforming growth factor-β (TGF-β)/(SMAD2) signaling. Molecular docking was done to investigate the possible inhibition of TGF-β by API and bioinformatic tools were utilized to investigate the correlation between the target proteins. Male Swiss albino mice were randomly distributed to four groups: Group I: a saline group, Group II: a METX control group (20 mg/kg, per week), Group III: METX + API (40 mg/kg, per day) and Group IV: METX + API (80 mg/kg, per day, via oral gavage); the study continued for three weeks. Our findings suggest that API administration significantly mitigated METX cardiotoxicity and serum CK-MB, likely through attenuation of the inflammatory cytokines (NF-κB, IL-1β, TNF-α, and IL-6) and suppression of cardiac TGF-β/SMAD2 signaling. The congruence between bioinformatics and experimental validation findings strongly highlighted API as a promising therapeutic candidate for alleviating METX cardiotoxicity. While the current data reveals key underlying molecular mechanisms for API′s cardioprotective effect, further comprehensive studies across diverse cardiotoxicity models are essential to fully elucidate cardioprotective effect of API.
Clinical Anatomy
Traditional anatomical resources like cadaveric dissection and professional atlases are the gold standard, but face constraints in cost and accessibility. The rapid integration of generative artificial intelligence (AI) in medical education offers new possibilities for custom anatomical illustration. Text-to-image AI generators provide an inexpensive and swift alternative for medical illustration. However, the anatomical fidelity and educational reliability of these models remain insufficiently validated. This study aimed to evaluate the accuracy of four prominent AI image generators in producing anatomically correct illustrations of the human heart, kidney, and brain. Four AI platforms-Copilot, Microsoft Designer, Gemini, and Freepik-were prompted to generate high-resolution, textbook-style illustrations of the heart (sternocostal view), kidney (coronal cross-section), and brain (lateral view). A total of 12 selected images were evaluated by a radiologist and two anatomists utilizing a structured 5-point Likert scale across five domains: textural realism, topological validity, morphometric accuracy, perspective and depth perception, and educational utility. Significant variability in performance was observed across platforms. Gemini consistently demonstrated superior performance, achieving perfect intraclass correlation coefficients (ICCs) and the highest ratings on complex topological tasks, including the representation of coronary vasculature and cortical sulci/gyri. Copilot showed high spatial accuracy in renal hilum organization. While all platforms showed high reliability and accuracy across broad morphological shapes (aortic arch, cerebral poles), accuracy declined sharply as anatomical complexity increased. AI-generated anatomical illustrations currently vary from medically indistinguishable to biologically impossible. While Gemini and Copilot show promise for supplemental educational use, the high frequency of hallucinated anatomical details in other platforms poses a risk for medical misinformation. The study underscores the necessity for expert supervision and for developing AI models trained on curated, peer-reviewed medical datasets.